Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient

被引：37
作者：
Pea, F
Scudeller, L
Lugano, M
Baccarani, U
Pavan, F
Tavio, M
Furlanut, M
Della Rocca, G
Bresadola, F
Viale, P
机构：
[1] Univ Udine, Inst Clin Pharmacol & Toxicol, DPMSC, Dept Expt & Clin Pathol & Med, I-33100 Udine, Italy
[2] Univ Udine, Clin Infect Dis, Dept Med & Morphol Res, I-33100 Udine, Italy
[3] Univ Udine, Sch Med, Dept Anesthesiol & Intens Care, I-33100 Udine, Italy
[4] Univ Udine, Sch Med, Dept Surg & Transplantat, I-33100 Udine, Italy
来源：
CLINICAL INFECTIOUS DISEASES | 2006年 / 42卷 / 03期
关键词：
D O I：
10.1086/499533
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：434 / 435
页数：2
相关论文
共 8 条
[1]   Linezolid-induced lactic acidosis. [J].
Apodaca, AA ;
Rakita, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :86-87
[2]   Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia [J].
Boselli, E ;
Breilh, D ;
Rimmelé, T ;
Djabarouti, S ;
Toutain, A ;
Chassard, D ;
Saux, MC ;
Allaouchiche, B .
CRITICAL CARE MEDICINE, 2005, 33 (07) :1529-1533
[3]   Linezolid and rifampin:: Drug interaction contrary to expectations? [J].
Egle, H ;
Trittler, R ;
Kümmerer, K ;
Lemmen, SW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (05) :451-453
[4]   Linezolid use associated with lactic acidosis [J].
Kopterides, P ;
Papadomichelakis, E ;
Armaganidis, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2005, 37 (02) :153-154
[5]   Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis? [J].
Palenzuela, L ;
Hahn, NM ;
Nelson, RP ;
Arno, JN ;
Schobert, C ;
Bethel, R ;
Ostrowski, LA ;
Sharma, MR ;
Datta, PP ;
Agrawal, RK ;
Schwartz, JE ;
Hirano, M .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (12) :E113-E116
[6]   Antimicrobial therapy in critically ill patients - A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability [J].
Pea, F ;
Viale, P ;
Furlanut, M .
CLINICAL PHARMACOKINETICS, 2005, 44 (10) :1009-1034
[7]  
PEA F, 2001, AM J KIDNEY, V44, P1094
[8]   Inhibition of P-glycoprotein by newer antidepressants [J].
Weiss, J ;
Dormann, G ;
Martin-Facklam, M ;
Kerpen, CJ ;
Ketabi-Kiyanvash, N ;
Haefeli, WE .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01) :197-204
1